ATP5B
Gene Information
- Official Symbol: ATP5F1B
- Official Name: ATP synthase F1 subunit beta
- Aliases and Previous Symbols: N/A
- Entrez ID: 506
- UniProt: P06576
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Subunits alpha and beta form the catalytic core in F(1). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits.
Pfam Domains GO Terms
Pfam Domains
| ATP-synt ab |
| ATP-synt ab C |
| ATP-synt ab N |
GO Terms
| proton-transporting ATP synthase complex, catalytic core F(1) |
| mitochondrial proton-transporting ATP synthase, catalytic core |
| proton-transporting ATP synthase complex |
| angiostatin binding |
| negative regulation of cell adhesion involved in substrate-bound cell migration |
| mitochondrial proton-transporting ATP synthase complex |
| proton-transporting ATP synthase activity, rotational mechanism |
| MHC class I protein binding |
| mitochondrial ATP synthesis coupled proton transport |
| proton-transporting ATPase activity, rotational mechanism |
| ATP synthesis coupled proton transport |
| energy coupled proton transport, down electrochemical gradient |
| substrate-dependent cell migration |
| response to interleukin-7 |
| cellular response to interleukin-7 |
| cristae formation |
| ATP biosynthetic process |
| mitochondrial nucleoid |
| inner mitochondrial membrane organization |
| purine ribonucleoside triphosphate biosynthetic process |
| purine nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate biosynthetic process |
| positive regulation of blood vessel endothelial cell migration |
| purine ribonucleoside triphosphate metabolic process |
| transmembrane transporter activity |
| nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate metabolic process |
| purine nucleoside triphosphate metabolic process |
| regulation of intracellular pH |
| regulation of blood vessel endothelial cell migration |
| regulation of cellular pH |
| nucleoside triphosphate metabolic process |
| mitochondrial transmembrane transport |
| regulation of pH |
| positive regulation of endothelial cell migration |
| mitochondrial membrane |
| cellular monovalent inorganic cation homeostasis |
| oxidative phosphorylation |
| osteoblast differentiation |
| mitochondrial membrane organization |
| monovalent inorganic cation homeostasis |
| positive regulation of epithelial cell migration |
| proton transmembrane transport |
| purine ribonucleotide biosynthetic process |
| purine nucleotide biosynthetic process |
| regulation of endothelial cell migration |
| ribonucleotide biosynthetic process |
| ribose phosphate biosynthetic process |
| purine-containing compound biosynthetic process |
| ATP metabolic process |
| mitochondrial transport |
| regulation of epithelial cell migration |
| ATPase activity |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| ossification |
| negative regulation of cell adhesion |
| purine ribonucleotide metabolic process |
| angiogenesis |
| ribonucleotide metabolic process |
| purine nucleotide metabolic process |
| ribose phosphate metabolic process |
| purine-containing compound metabolic process |
| mitochondrial matrix |
| monovalent inorganic cation transport |
| blood vessel morphogenesis |
| generation of precursor metabolites and energy |
| mitochondrion organization |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| blood vessel development |
| drug metabolic process |
| positive regulation of cell migration |
| vasculature development |
| cardiovascular system development |
| positive regulation of cell motility |
| organophosphate biosynthetic process |
| positive regulation of cellular component movement |
| nucleobase-containing small molecule metabolic process |
| positive regulation of locomotion |
| inorganic cation transmembrane transport |
| cation transmembrane transport |
| cell surface |
| carbohydrate derivative biosynthetic process |
| cellular cation homeostasis |
| cellular ion homeostasis |
| inorganic ion transmembrane transport |
| tube morphogenesis |
| regulation of cell adhesion |
| cation homeostasis |
| inorganic ion homeostasis |
| cellular chemical homeostasis |
| ion homeostasis |
| cation transport |
| tube development |
| regulation of cell migration |
| membrane organization |
| circulatory system development |
| organophosphate metabolic process |
| anatomical structure formation involved in morphogenesis |
| cellular homeostasis |
| regulation of cell motility |
| ion transmembrane transport |
| cell migration |
| regulation of locomotion |
| regulation of cellular component movement |
| cellular response to cytokine stimulus |
| carbohydrate derivative metabolic process |
| localization of cell |
| cell motility |
| nucleobase-containing compound biosynthetic process |
| response to cytokine |
| chemical homeostasis |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| lipid metabolic process |
| mitochondrion |
| transmembrane transport |
| phosphorylation |
| organic cyclic compound biosynthetic process |
| locomotion |
| ion transport |
| organonitrogen compound biosynthetic process |
| ATP binding |
| intracellular transport |
| movement of cell or subcellular component |
| cellular nitrogen compound biosynthetic process |
| homeostatic process |
| positive regulation of multicellular organismal process |
| small molecule metabolic process |
| establishment of localization in cell |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| ATP5O | 0.844 |
| ATP5A1 | 0.782 |
| ATP5D | 0.767 |
| ATP5C1 | 0.693 |
| ATP5F1 | 0.633 |
| ATP5J | 0.628 |
| ATP5L | 0.614 |
| ATP5E | 0.602 |
| ATP5H | 0.599 |
| ATP5I | 0.586 |
| TRIAP1 | 0.584 |
| TMEM242 | 0.568 |
| THG1L | 0.561 |
| BCS1L | 0.56 |
| SLC25A26 | 0.554 |
| DPAGT1 | 0.552 |
| COX16 | 0.551 |
| MRPL21 | 0.549 |
| HSPD1 | 0.548 |
| FH | 0.545 |
| DOHH | 0.543 |
| PMM2 | 0.531 |
| HCCS | 0.53 |
| HSD17B10 | 0.53 |
| GFPT1 | 0.53 |
| ATP5J2 | 0.53 |
| DARS2 | 0.529 |
| UBE2G2 | 0.527 |
| SUPV3L1 | 0.523 |
| PPA2 | 0.52 |
| ELAC2 | 0.518 |
| ZRSR2 | 0.507 |
| DAP3 | 0.504 |
| TRNT1 | 0.504 |
| UAP1 | 0.503 |
| MRPS14 | 0.503 |
| DOLK | 0.499 |
| YARS2 | 0.499 |
| WBSCR16 | 0.495 |
| ATXN10 | 0.494 |
| MED16 | 0.494 |
| ADSL | 0.493 |
| SELRC1 | 0.493 |
| MRPS16 | 0.492 |
| GMPPB | 0.491 |
| ALG1 | 0.489 |
| KIAA0391 | 0.488 |
| COX7B | 0.488 |
| MRPS26 | 0.488 |
| RARS2 | 0.487 |
| ALG6 | 0.486 |
| MBTPS2 | 0.485 |
| RNMT | 0.482 |
| ALG13 | 0.479 |
| MRPS6 | 0.478 |
| HARS2 | 0.478 |
| VEZT | 0.478 |
| PARS2 | 0.477 |
| PDSS1 | 0.477 |
| MRPL20 | 0.475 |
| RPP21 | 0.474 |
| SSB | 0.474 |
| ENY2 | 0.471 |
| PNPT1 | 0.47 |
| RTCB | 0.47 |
| MRPS21 | 0.47 |
| OPA1 | 0.47 |
| UBA5 | 0.469 |
| CASP9 | 0.469 |
| TUFM | 0.469 |
| DHPS | 0.468 |
| CYCS | 0.468 |
| MRP63 | 0.467 |
| NDUFAF4 | 0.466 |
| ROMO1 | 0.465 |
| RPTOR | 0.463 |
| C10orf2 | 0.462 |
| GFM1 | 0.462 |
| TMEM41B | 0.46 |
| RPUSD4 | 0.459 |
| TEFM | 0.459 |
| TAMM41 | 0.458 |
| PPP6C | 0.457 |
| GATC | 0.456 |
| SCO2 | 0.456 |
| LSM10 | 0.455 |
| ALG5 | 0.455 |
| MRPL47 | 0.455 |
| TAZ | 0.452 |
| GTF3C6 | 0.452 |
| GTF3C4 | 0.452 |
| SARS2 | 0.449 |
| CBFB | 0.449 |
| FASTKD5 | 0.449 |
| BAP1 | 0.444 |
| MRPL23 | 0.444 |
| VARS2 | 0.443 |
| TRMT5 | 0.443 |
| LARS2 | 0.442 |
| UQCRC2 | 0.442 |
| ZBTB11 | 0.441 |
| MRPS34 | 0.44 |
| KDSR | 0.44 |
| C17orf89 | 0.44 |
| TARS2 | 0.439 |
| C1orf27 | 0.436 |
| NDUFC2 | 0.434 |
| MRPS18A | 0.433 |
| MARS2 | 0.432 |
| NDUFB3 | 0.431 |
| MRPS11 | 0.43 |
| MRPS33 | 0.429 |
| NARS2 | 0.428 |
| PLAA | 0.427 |
| WDR59 | 0.427 |
| DHRSX | 0.427 |
| URM1 | 0.426 |
| NAE1 | 0.424 |
| CRLS1 | 0.423 |
| HIST1H2BK | 0.423 |
| MRPS9 | 0.423 |
| DR1 | 0.422 |
| MRPS5 | 0.422 |
| AARS | 0.42 |
| RTN4IP1 | 0.419 |
| DNLZ | 0.418 |
| SDHA | 0.417 |
| CHCHD4 | 0.417 |
| DNAJC3 | 0.417 |
| UHRF1 | 0.416 |
| NDUFB5 | 0.415 |
| ALG2 | 0.415 |
| EARS2 | 0.415 |
| COX15 | 0.414 |
| EGLN1 | 0.414 |
| FAF2 | 0.412 |
| MRPS2 | 0.412 |
| SLC25A19 | 0.412 |
| GFM2 | 0.411 |
| TRMT10A | 0.411 |
| PPCS | 0.41 |
| DDX1 | 0.41 |
| BAK1 | 0.409 |
| GNB1L | 0.408 |
| SERF2 | 0.407 |
| SLC35B1 | 0.407 |
| APAF1 | 0.407 |
| LAMTOR5 | 0.407 |
| TIMM13 | 0.407 |
| EXOC4 | 0.405 |
| RFT1 | 0.405 |
| TXNL4B | 0.405 |
| UQCR10 | 0.405 |
| MRPS25 | 0.404 |
| MRPS23 | 0.404 |
| GTF3C3 | 0.404 |
| NDUFA3 | 0.403 |
| SLC25A52 | 0.403 |
| GTPBP10 | 0.402 |
| SEC62 | 0.402 |
| COX5A | 0.402 |
| PGGT1B | 0.401 |
| TTI1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 227/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 1/1 |
| bile duct | 8/28 |
| blood | 8/28 |
| bone | 8/26 |
| breast | 14/33 |
| central nervous system | 14/56 |
| cervix | 3/4 |
| colorectal | 7/17 |
| esophagus | 5/13 |
| fibroblast | 0/1 |
| gastric | 6/16 |
| kidney | 7/21 |
| liver | 9/20 |
| lung | 27/75 |
| lymphocyte | 1/16 |
| ovary | 3/26 |
| pancreas | 6/24 |
| peripheral nervous system | 2/16 |
| plasma cell | 4/15 |
| prostate | 0/1 |
| skin | 8/24 |
| soft tissue | 5/9 |
| thyroid | 0/2 |
| upper aerodigestive | 6/22 |
| urinary tract | 7/29 |
| uterus | 2/5 |
Essentiality in NALM6
- Essentiality Rank: 865
- Expression level (log2 read counts): 9.6
Expression Distribution
ATP5B Expression in NALM6 Cells: 9.6